Surging global prevalence of chronic obstructive pulmonary disease (COPD), heart failure, and complex cardiopulmonary comorbidities, expanding aging demographics requiring continuous respiratory and cardiac monitoring, and continuous medical device and biopharmaceutical innovations in advanced spirometry, cardiac biomarkers, and extracorporeal life support systems are driving rapid growth...